| Originalsprog | Engelsk |
|---|---|
| Publikationsdato | 2013 |
| Status | Udgivet - 2013 |
| Begivenhed | EANM kongres 2013 - Lyon, Frankrig Varighed: 19. okt. 2013 → 23. okt. 2013 |
Konference
| Konference | EANM kongres 2013 |
|---|---|
| Land | Frankrig |
| By | Lyon |
| Periode | 19/10/2013 → 23/10/2013 |
Citer dette
Rasmussen, J., Poulsen, M. H., Johansen, A., Lund, L., Høilund-Carlsen, P. F., & Gerke, O. (2013). Bone scan index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients. Poster session præsenteret på EANM kongres 2013, Lyon, Frankrig.
@conference{a7d3e8cbc13b4168a20f285f00d7d5d5,
title = "Bone scan index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients",
author = "Janne Rasmussen and Poulsen, {Mads Hvid} and Allan Johansen and Lars Lund and H{\o}ilund-Carlsen, {Poul Flemming} and Oke Gerke",
year = "2013",
language = "English",
note = "null ; Conference date: 19-10-2013 Through 23-10-2013",
}
Rasmussen, J, Poulsen, MH, Johansen, A, Lund, L, Høilund-Carlsen, PF & Gerke, O 2013, 'Bone scan index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients' EANM kongres 2013, Lyon, Frankrig, 19/10/2013 - 23/10/2013, .
Bone scan index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients. / Rasmussen, Janne ; Poulsen, Mads Hvid; Johansen, Allan; Lund, Lars; Høilund-Carlsen, Poul Flemming; Gerke, Oke.
2013. Poster session præsenteret på EANM kongres 2013, Lyon, Frankrig.Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review
TY - CONF
T1 - Bone scan index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients
AU - Rasmussen, Janne
AU - Poulsen, Mads Hvid
AU - Johansen, Allan
AU - Lund, Lars
AU - Høilund-Carlsen, Poul Flemming
AU - Gerke, Oke
PY - 2013
Y1 - 2013
M3 - Poster
ER -
Rasmussen J, Poulsen MH, Johansen A, Lund L, Høilund-Carlsen PF, Gerke O. Bone scan index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients. 2013. Poster session præsenteret på EANM kongres 2013, Lyon, Frankrig.